ContraVir Pharmaceuticals, Inc. Warrant Agreements
19 Contracts & Agreements
- Form of Amendment No. 1 to Series ACommon Stock Purchase Warrant (Filed With SEC on February 16, 2024)
- Form of Warrant Inducement Agreement (Filed With SEC on February 16, 2024)
- Form of Series B-2 Warrant (Filed With SEC on February 16, 2024)
- Form of Series B-1 Warrant (Filed With SEC on February 16, 2024)
- Form of Series B Warrant (Filed With SEC on October 3, 2023)
- Form of Series A Warrant (Filed With SEC on October 3, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 3, 2023)
- Form of Representatives Warrant (Filed With SEC on November 20, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on November 20, 2020)
- Form of Common Stock Purchase Warrant dated June 14, 2018 (Filed With SEC on November 12, 2020)
- Form of Warrant (Filed With SEC on June 5, 2019)
- Form of Warrant (Filed With SEC on April 18, 2019)
- Warrant Agency Agreement, dated as of July 2, 2018, by and between the Company and Philadelphia Stock Transfer, Inc (Filed With SEC on July 5, 2018)
- Form of Warrant Certificate (Filed With SEC on June 4, 2018)
- Form of Warrant Agreement (Filed With SEC on June 4, 2018)
- [FORM OF WARRANT] (Filed With SEC on April 25, 2017)
- CONTRAVIR PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 30, 2016)
- CONTRAVIR PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 7, 2015)
- COMMON STOCK PURCHASE WARRANT CONTRAVIR PHARMACEUTICALS, INC. (Filed With SEC on February 5, 2014)
